ECSP982481A - PROTEASE INHIBITORS - Google Patents
PROTEASE INHIBITORSInfo
- Publication number
- ECSP982481A ECSP982481A ECSP982481A ECSP982481A EC SP982481 A ECSP982481 A EC SP982481A EC SP982481 A ECSP982481 A EC SP982481A EC SP982481 A ECSP982481 A EC SP982481A
- Authority
- EC
- Ecuador
- Prior art keywords
- disease
- cartilage
- excessive
- degeneration
- present
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 210000000845 cartilage Anatomy 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 206010065687 Bone loss Diseases 0.000 abstract 2
- 230000007850 degeneration Effects 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 102000004171 Cathepsin K Human genes 0.000 abstract 1
- 108090000625 Cathepsin K Proteins 0.000 abstract 1
- 208000037147 Hypercalcaemia Diseases 0.000 abstract 1
- 208000030136 Marchiafava-Bignami Disease Diseases 0.000 abstract 1
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 208000010191 Osteitis Deformans Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000027868 Paget disease Diseases 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 208000007565 gingivitis Diseases 0.000 abstract 1
- 230000000148 hypercalcaemia Effects 0.000 abstract 1
- 208000030915 hypercalcemia disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 208000027202 mammary Paget disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 201000001245 periodontitis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona compuestos que inhiben proteasas, incluyendo catepsina K, composiciones farmacéuticas de tales compuestos, y métodos para tratar enfermedades de excesiva pérdida ósea o degeneración de cartílago o degradación de cartílago o matriz, incluyendo osteoporosis; enfermedad gigival, incluyendo gingivitis y periodontitis; artritis, más especificamente, osteoartritis y artritis reumatoide; enfermedad de Paget; hipercalcemia de enfermedades malignas; y enfermedad ósea metabólica, que comprende inhibir dicha pérdida ósea o degeneración excesiva de cartílago o matriz administrando un compuesto de la presente invención a un paciente con necesidad de ello.The present invention provides compounds that inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, and methods of treating diseases of excessive bone loss or cartilage degeneration or cartilage or matrix degradation, including osteoporosis; gigival disease, including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignant diseases; and metabolic bone disease, which comprises inhibiting said bone loss or excessive cartilage or matrix degeneration by administering a compound of the present invention to a patient in need thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982481 ECSP982481A (en) | 1998-04-22 | 1998-04-22 | PROTEASE INHIBITORS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982481 ECSP982481A (en) | 1998-04-22 | 1998-04-22 | PROTEASE INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982481A true ECSP982481A (en) | 1999-01-19 |
Family
ID=42043403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982481 ECSP982481A (en) | 1998-04-22 | 1998-04-22 | PROTEASE INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982481A (en) |
-
1998
- 1998-04-22 EC ECSP982481 patent/ECSP982481A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9801222A0 (en) | Proatease inhibitors. | |
| GC0000178A (en) | Protease inhibitors | |
| MY141596A (en) | Protease inhibitors | |
| BR9809333A (en) | Protease inhibitors | |
| WO1999059526A3 (en) | Protease inhibitors | |
| EA200300018A1 (en) | PROTEAS INHIBITORS | |
| HK1042695A1 (en) | Prothease inhibitors | |
| UY26088A1 (en) | PROTEASE INHIBITORS | |
| UY26026A1 (en) | PROTEASE INHIBITORS | |
| HK1041690A1 (en) | Protease inhibitors | |
| WO2002092563A3 (en) | Protease inhibitors | |
| ECSP982481A (en) | PROTEASE INHIBITORS | |
| UY27032A1 (en) | PROTEASE INHIBITORS | |
| ECSP982486A (en) | PROTEASE INHIBITORS II | |
| UY24550A1 (en) | PROTEASE INHIBITORS | |
| ECSP003403A (en) | PROTEASE INHIBITORS XI | |
| ECSP992959A (en) | BIS-AMINOMETIL CARBONYL PROTEASE INHIBITORS | |
| ECSP982493A (en) | PROTEASE INHIBITORS III | |
| ECSP993293A (en) | PROTEASE INHIBITORS VIII | |
| AR021971A1 (en) | PROTEASE INHIBITORS | |
| UY26771A1 (en) | PROTEASE INHIBITORS | |
| NZ324101A (en) | Protease inhibitors, pharmaceutical compositions and use thereof | |
| ECSP003353A (en) | PROTEASE INHIBITORS IX |